Drug delivery system comprising a reservoir containing a plurality of tiny pills
First Claim
Patent Images
1. A device dimensioned and adapted for oral admittance into a gastro intestinal tract environment of use for extended residency into the fluid environment of the stomach as an in vivo resevoir for executing therein a therapeutic program over a prolonged period of time, the device comprising;
- (a) a matrix formed of a pharmaceutically acceptable non-toxic, non-hydrated hydrogel that absorbs and imbibes fluid from the fluid environment of the stomach, expands and swells exhibiting a 2 to 50 fold volume increase for retaining the device in the stomach over an extended period of time, said hydrogel being a hydrophilic hydrogel that is non cross-linked or a hydrophilic hydrogel cross-linked with acid mobile covalent or ionic bonds, said hydrophilic hydrogel selected from the group consisting of naturally occurring or synthetic polymeric materials and colloids;
(b) a plurality of tiny pills dispersed throughout the matrix, the tiny pills comprising;
(1) a core of beneficial drug; and
,(2) a wall formed of a drug release rate controlling fatty acid and wax wall composition that surrounds the core of beneficial drug, and,(c) wherein, when the device is in the environment of use, the device executes the therapeutic program by delivering drug in the stomach for absorption in the stomach, and for passage into the intestine for absorption in the intestine.
1 Assignment
0 Petitions
Accused Products
Abstract
A delivery device is disclosed for delivering a beneficial drug to a biological environment of use. The device comprises a hydrogel reservoir containing tiny pills. The tiny pills comprise a wall surrounding a drug core.
224 Citations
2 Claims
-
1. A device dimensioned and adapted for oral admittance into a gastro intestinal tract environment of use for extended residency into the fluid environment of the stomach as an in vivo resevoir for executing therein a therapeutic program over a prolonged period of time, the device comprising;
-
(a) a matrix formed of a pharmaceutically acceptable non-toxic, non-hydrated hydrogel that absorbs and imbibes fluid from the fluid environment of the stomach, expands and swells exhibiting a 2 to 50 fold volume increase for retaining the device in the stomach over an extended period of time, said hydrogel being a hydrophilic hydrogel that is non cross-linked or a hydrophilic hydrogel cross-linked with acid mobile covalent or ionic bonds, said hydrophilic hydrogel selected from the group consisting of naturally occurring or synthetic polymeric materials and colloids; (b) a plurality of tiny pills dispersed throughout the matrix, the tiny pills comprising; (1) a core of beneficial drug; and
,(2) a wall formed of a drug release rate controlling fatty acid and wax wall composition that surrounds the core of beneficial drug, and, (c) wherein, when the device is in the environment of use, the device executes the therapeutic program by delivering drug in the stomach for absorption in the stomach, and for passage into the intestine for absorption in the intestine. - View Dependent Claims (2)
-
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeALZA Corporation (Johnson & Johnson)
-
Original AssigneeALZA Corporation (Johnson & Johnson)
-
InventorsUrquhart, John, Theeuwes, Felix
-
Primary Examiner(s)Moyer, Donald B.
-
Assistant Examiner(s)Faraci, C. Joseph
-
Application NumberUS06/360,477Time in Patent Office708 DaysField of Search424/360, 424/16, 424/19, 424/22, 424/35, 128/260, 604/890, 604/892US Class Current424/469CPC Class CodesA61K 9/0065 Forms with gastric retentio...A61K 9/2077 Tablets comprising drug-con...
